Product
QRX003-4%
1 clinical trial
1 indication
Indication
Netherton SyndromeClinical trial
A Multicenter, Randomized, Vehicle-Controlled, Double-Blind, Parallel Comparison Study of QRX003 Lotion in Subjects With Netherton SyndromeStatus: Recruiting, Estimated PCD: 2025-01-31